Testis biopsy: Integral to workup of infertile men
February 1st 2006Montreal--Spermatogenesis markers that can be easily obtained from a noninvasive testis biopsy may predict which patients will respond to surgical varicocele repair. Testis biopsy, therefore, should be part of the regular workup for male infertility patients, suggest the authors of the 2005 Society for Male Reproduction and Urology Prize paper presented here at the American Society for Reproductive Medicine annual meeting.
Age continues to affect assisted reproductive technology outcomes
January 19th 2006In 2003, more than 48,000 babies were born in the United States as a result of assisted reproductive technology (ART) procedures, according to a new report from the Centers for Disease Control and Prevention. This marks an increase from 45,751 babies in 2002.
Study: Statins do not reduce incidence of prostate, other cancers
January 19th 2006Contrary to previous reports, statins do not appear to reduce the incidence of cancer or cancer deaths, according to a meta-analysis of previous studies (JAMA 2006; 295:74-80). The finding held true for a range of cancers, including prostate cancer.
Urine test improves detection of recurrent bladder cancer
January 19th 2006The NMP22 test (BladderChek, Matritech, Newton, MA) significantly increased the detection of recurrent bladder cancer, finding 99% of the malignancies when used with cystoscopy, according to a study published this week in JAMA (2006; 295:299-305).
HHS commits to expanding ASC service coverage
January 5th 2006Over the next 2 years, the U.S. Department of Health and Human Services will undertake two key initiatives to expand Medicare beneficiary access to services provided by ambulatory surgery centers, the American Association of Ambulatory Surgery Centers reported.
Calcitriol-chemo combo improves prostate cancer survival
January 1st 2006Paris--Adding a form of high-dose calcitriol to docetaxel (Taxotere) offers improved survival over docetaxel alone in men with metastatic androgen-independent prostate cancer, according to results of a multicenter trial presented at the 13th European Cancer Conference (ECCO-13) here. Further, the addition of the calcitriol formulation, known as DN-101, to the chemotherapy agent produced an unanticipated advantage in a reduced number of serious gastrointestinal and thromboembolic adverse events.
Hands-on lap course has 'high impact' on practices
January 1st 2006Amsterdam, Netherlands--Participants in an AUA-sponsored laparoscopic videotape mentoring course, offered as part of a skills-based learning course, report an increase in their laparoscopic caseload and in the performance of clinical laparoscopic suturing.
Hire the best: How to select a physician recruiter
January 1st 2006Whether you're interested in adding an associate to your practice or are seeking a move yourself, you're likely to en-counter physician recruiters. While working with a recruiter is not for every physician, it can save time and allow you to focus on what really matters: patient care.
No reconstruction modality for PCNL is perfect
January 1st 2006Amsterdam, Netherlands--Three-dimensional computed tomography reconstruction of the pelvicalyceal system helps in the planning and execution of percutaneous nephrolithotomy, but the relative value of each reconstruction method is not known.
Tubeless PNL yields high stone-free rates, less pain
January 1st 2006Amsterdam, Netherlands--With U.S. experience with tubeless percutaneous nephrolithotomy (PNL) now reaching 9 years, several studies have demonstrated the procedure's safety and effectiveness. Stone-free rates are similar to that seen with standard PNL using nephrostomy tubes, but postoperative hospitalization and narcotic use are decreased with the tubeless procedure, according to study results presented at the World Congress on Endourology here.
Hazards make finding the right laser sheath critical
January 1st 2006Amsterdam, Netherlands--A protective polyamide laser sheath for use during flexible ureteroscopy and laser lithotripsy showed little effect on deflection characteristics but markedly impaired irrigation flow in a new study from Canada.
Post-RP radiation improves progression-free survival
January 1st 2006Paris--External irradiation immediately following radical prostatectomy appears to improve biochemical progression-free survival and local control in prostate cancer patients at high risk of progression, according to results of a study from the European Organization for Research and Treatment of Cancer (EORTC).
Immunotherapy shows survival advantage in advanced prostate cancer
January 1st 2006Paris--Results of a second phase III trial suggest that a still-investigational immunotherapy agent offers a survival benefit in men with asymptomatic metastatic androgen-independent prostate cancer. Survival data from the more recent study support the findings of the first phase III trial of the agent, APC8015, also known as sipuleucel-T (Provenge), researchers reported at the European Cancer Conference here.